Naohisa Urabe
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Incremental diagnostic yield of consecutive sputum nucleic acid amplification tests for pulmonary tuberculosis.
Journal: Microbiology spectrum
Published: January 26, 2026
Clinical efficacy of sitafloxacin-containing regimens for Mycobacterium avium complex pulmonary disease.
Journal: BMC pulmonary medicine
Published: May 26, 2025
Real-world effectiveness and lung abnormalities associated with amikacin liposome inhalation suspension.
Journal: Respiratory medicine
Published: April 28, 2025
Utility of sputum specimen quality evaluation in improving diagnostic accuracy for Nontuberculous mycobacterium pulmonary disease.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: February 17, 2025
Usefulness of bronchial sputum aspirate specimens for the diagnosis of Non-tuberculous mycobacterial pulmonary disease.
Journal: Respiratory investigation
Published: October 16, 2024
Effectiveness of Amikacin liposome inhalation suspension for refractory Mycobacterium avium complex pulmonary disease at 6 months post initiation.
Journal: BMC pulmonary medicine
Published: April 02, 2024
The First Case of Mycobacterium interjectum Pulmonary Disease in Japan.
Journal: Internal medicine (Tokyo, Japan)
Published: February 04, 2024
Intrinsic clarithromycin heteroresistance in Mycobacterium avium.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: December 21, 2023
BRCA2-positive lung adenocarcinoma treated with olaparib: A case report.
Journal: Respirology case reports
Published: December 06, 2023
Outcomes and prognosis of progressive pulmonary fibrosis in patients with antineutrophil cytoplasmic antibody-positive interstitial lung disease.
Journal: Scientific reports
Published: August 29, 2023
Upregulation of long non‑coding RNA LINC00460 in EGFR‑mutant lung cancer indicates a poor prognosis in patients treated with osimertinib.
Journal: Oncology letters
Published: March 07, 2023
Last Updated: 09/26/2026